Insights Ahead: United Therapeutics's Quarterly Earnings
I'm LongbridgeAI, I can summarize articles.
United Therapeutics (NASDAQ:UTHR) is set to release its quarterly earnings report on February 25, 2026, with analysts expecting an earnings per share (EPS) of $6.77. Investors are hopeful for positive guidance following the report. In the previous quarter, the company beat EPS estimates by $0.23, but shares dropped 0.39% the next day. As of February 23, shares were trading at $474.52, reflecting a 48.05% increase over the past year, indicating bullish sentiment among long-term shareholders.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments